Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Boehringer-Ingelheim
Company Monitoring Page for Boehringer-Ingelheim
latest headlines for company on cafepharma
Zantac Lawsuit: Illinois Jury Rules in Favor of Boehringer Ingelheim
Lawyer Monthly
Tue, 02/25/25 - 10:41 pm
Tags:
Boehringer Ingelheim
,
Zantac
,
Illinois
,
prostate cancer
,
legal
Boehringer and partners commence gene therapy trial for cystic fibrosis
Clinical Trials Arena
Fri, 02/21/25 - 10:49 am
Tags:
Boehringer Ingelheim
,
gene therapy
,
cystic fibrosis
,
clinical trials
Boehringer eyes third quarter FDA verdict for oral HER2 drug
Pharmaphorum
Thu, 02/20/25 - 11:29 am
Tags:
Boehringer Ingelheim
,
zongertinib
,
FDA
,
metastatic non-small cell lung cancer
ExpressionEdits and Boehringer Ingelheim partner to optimize gene therapies
Pharmaceutical Business Review
Fri, 02/14/25 - 09:15 am
Tags:
Boehringer Ingelheim
,
ExpressionEdits
,
gene therapy
Boehringer's phase 3 schizophrenia program misses primary goal
Fierce Biotech
Thu, 01/16/25 - 09:39 pm
Tags:
Boehringer Ingelheim
,
schizophrenia
,
clinical trials
,
iclepertin
Boehringer Ingelheim drops obesity drug from Gubra partnership
Fierce Biotech
Thu, 10/31/24 - 10:45 pm
Tags:
Boehringer Ingelheim
,
Gubra
,
obesity
Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug
Fierce Biotech
Tue, 10/15/24 - 10:17 am
Tags:
Notable Labs
,
Boehringer Ingelheim
,
oncology
,
bankruptcy
,
volasertib
Boehringer unveils $607M deal to land Circle's preclinical cancer program
Fierce Biotech
Wed, 10/9/24 - 09:55 am
Tags:
Boehringer Ingelheim
,
Circle Pharma
,
cancer
,
drug development
Boehringer kickstarts two Phase III trials as MASH therapy wins breakthrough status
Clinical Trials Arena
Tue, 10/8/24 - 09:56 am
Tags:
Boehringer Ingelheim
,
MASH
,
clinical trials
,
survodutide
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tue, 10/8/24 - 09:45 am
Tags:
R&D
,
obesity
,
weight loss
,
Novo Nordisk
,
Eli Lilly
,
Roche
,
Boehringer Ingelheim
Boehringer Ingelheim and Veeva: A data partnership for One Medicine
Pharmaphorum
Fri, 10/4/24 - 09:18 am
Tags:
Boehringer Ingelheim
,
Veeva
,
One Medicine Platform
,
Clinical Data
Boehringer's phase 3 lung fibrosis trial hits primary endpoint, teeing up filings for Ofev successor
Fierce Biotech
Mon, 09/16/24 - 10:57 am
Tags:
Boehringer Ingelheim
,
IPF
,
clinical trials
,
nerandomilast
Boehringer Ingelheim reports positive results from trial of HER2 lung cancer drug
Clinical Trials Arena
Tue, 09/10/24 - 08:35 am
Tags:
Boehringer Ingelheim
,
clinical trials
,
zongertinib
,
non-small cell lung cancer
Boehringer adds to cancer drug pipeline with deal for startup Nerio
BioPharma Dive
Mon, 07/29/24 - 11:01 am
Tags:
Boehringer Ingelheim
,
M&A
,
Nerio Therapeutics
,
immuno-oncology
GoodRx teams with Boehringer on Humira biosimilar
Axios
Thu, 07/18/24 - 11:21 am
Tags:
GoodRx
,
Boehringer Ingelheim
,
biosimilars
,
Humira
Boehringer backs Brainomix AI software for lung fibrosis
Pharmaphorum
Thu, 07/18/24 - 11:08 am
Tags:
Boehringer Ingelheim
,
digital health
,
lung fibrosis
,
Brainomix
,
artificial intelligence
Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling
BioSpace
Mon, 07/8/24 - 11:38 am
Tags:
Boehringer Ingelheim
,
Inflation Reduction Act
,
legal
,
Medicare
,
drug pricing
Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity
Clinical Trials Arena
Tue, 07/2/24 - 11:19 am
Tags:
Boehringer Ingelheim
,
Gubra
,
clinical trials
,
BI 3034701
,
obesity
With 2 planned launches, Boehringer Ingelheim looks to make a name for itself in oncology
Fierce Pharma
Mon, 06/10/24 - 06:07 pm
Tags:
Boehringer Ingelheim
,
oncology
,
ASCO 2024
,
DDLPS
,
glioblastoma
Boehringer, Lilly face off in MASH at EASL
Pharmaphorum
Mon, 06/10/24 - 11:14 am
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
MASH
,
EASL
,
tirzepatide
,
survodutide
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.